- Home
- DOCS vs ARCC Comparison
DOCS vs ARCC Comparison
Compare DOCS & ARCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DOCS
- ARCC
- Stock Information
- Founded
- DOCS 2010
- ARCC 2004
- Country
- DOCS United States
- ARCC United States
- Employees
- DOCS N/A
- ARCC N/A
- Industry
- DOCS Retail: Computer Software & Peripheral Equipment
- ARCC Finance/Investors Services
- Sector
- DOCS Technology
- ARCC Finance
- Exchange
- DOCS Nasdaq
- ARCC Nasdaq
- Market Cap
- DOCS 13.7B
- ARCC 15.8B
- IPO Year
- DOCS 2021
- ARCC 2004
- Fundamental
- Price
- DOCS $71.11
- ARCC $19.80
- Analyst Decision
- DOCS Buy
- ARCC Buy
- Analyst Count
- DOCS 19
- ARCC 9
- Target Price
- DOCS $68.68
- ARCC $23.00
- AVG Volume (30 Days)
- DOCS 1.4M
- ARCC 5.8M
- Earning Date
- DOCS 11-06-2025
- ARCC 10-28-2025
- Dividend Yield
- DOCS N/A
- ARCC 9.67%
- EPS Growth
- DOCS 45.79
- ARCC N/A
- EPS
- DOCS 1.17
- ARCC 2.03
- Revenue
- DOCS $589,636,000.00
- ARCC $3,011,000,000.00
- Revenue This Year
- DOCS $13.33
- ARCC $3.21
- Revenue Next Year
- DOCS $10.90
- ARCC $5.09
- P/E Ratio
- DOCS $60.92
- ARCC $9.77
- Revenue Growth
- DOCS 19.45
- ARCC 6.85
- 52 Week Low
- DOCS $40.87
- ARCC $18.26
- 52 Week High
- DOCS $85.21
- ARCC $23.84
- Technical
- Relative Strength Index (RSI)
- DOCS 49.49
- ARCC 24.88
- Support Level
- DOCS $69.16
- ARCC $20.03
- Resistance Level
- DOCS $74.33
- ARCC $20.43
- Average True Range (ATR)
- DOCS 2.20
- ARCC 0.39
- MACD
- DOCS -0.55
- ARCC -0.07
- Stochastic Oscillator
- DOCS 23.88
- ARCC 0.26
About DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
About ARCC Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.